Peer-reviewed results in Molecular Therapy Oncology show that targeted, mutation-agnostic CRISPR gene editing of NRF2 in head and neck cancer models resensitizes treatment resistant tumors to ...
Glucocorticoid-induced osteoporosis (GIOP) remains a major clinical challenge, affecting up to half of patients receiving long-term glucocorticoid therapy. Excessive oxidative stress and impaired ...